 Email this article to a friend  Printable Version FREE Email Newsletter
Support NaturalNews advertisers - Advertise with NaturalNews
 Nutrition Can Save America!
FREE report by Mike Adams, the Health Ranger, reveals why nutritional deficiencies are destroying America's health and economy... and how to restore America's future with real food.
|
|
(NaturalNews opinion) The latest round of scientific fraud from Big Pharma arrives in the form of yet more junk science conducted by Merck on its blockbuster cholesterol drug Vytorin. Results of a clinical trial involving the drug were finally released this week, nearly two years after they were known by Merck, and only after Merck attempted to manipulate the data by redefining the outcome of the trial after the fact!
To help explain the degree of scientific fraud happening with this Vytorin clinical trial, I've released a sixty-second parody video ad featuring Merck's Vytorin drug along with a narrative explanation of the fraud surrounding Vytorin. You can watch the video here: http://www.NaturalNews.com/022501.html
Deliberate Fraud: What Really Happened with VytorinVytorin has been a top-selling cholesterol drug for several years, generating billions of dollars in revenue for Merck and Schering-Plough. Even though the drug was being prescribed to millions of people, nobody really knew if it worked to remove plaque from arteries (which sort of makes you wonder why it was approved in the first place, right?), so Merck launched a clinical trial called ENHANCE to study the effectiveness of the drug.
The ENHANCE study was completed in April, 2006, and the results were turned over to Merck. As it turns out, Merck didn't like the results of the trial, so instead of releasing them to the public (or the FDA), it sat on them, delaying the release of this data while Vytorin sales continued to ring up billions of dollars in sales.
After sitting on the data for over a year, Merck decided it would commit scientific fraud and "redefine" the goal of the study after the fact! This would involve selectively deciding which data points looked the best, and then reshaping the goal of the study to fit the data. (How's that for "evidence-based medicine?" The deeper you look into the so-called "science" behind Big Pharma's pill-pushing agenda, the more you realize it's based on nothing but fraud...)
When the scientific community got word of this after-the-fact redefinition of the study, they were outraged and demanded that Merck abide by established scientific guidelines. Merck then abandoned its plan to manipulate the goal of the study and decided to sit on the data for several more months.
Finally, after the threat of a Congressional investigation -- and spurred by numerous critics accusing Merck of hiding undesirable study results -- the company agreed to release the results of the clinical trial. And what did the results show? Steven Nissen, head of cardiology at the Cleveland Clinic, said, "This drug doesn't work. Period. It just doesn't work. ... In fact, the data on both the rate of progression of atherosclerosis and cardiovascular events are trending in the wrong direction. This is a pretty clear failure. Physicians should now stop using ezetimibe or Vytorin except as a last resort."
In other words, the clinical trial results showed Vytorin to be a complete failure at reducing arterial plaque. This brings up three hugely important questions for modern medicine:
Question 1: Why was Vytorin approved by the FDA if it didn't work?I find it curious that this test to determine whether Vytorin actually works was being conducted after it was approved by the FDA, don't you? As it turns out, all the millions of people who were prescribed Vytorin were being used as human guinea pigs, shelling out their hard-earned cash for a drug that was medically worthless. So why did the FDA approve Vytorin in the first place? Doesn't the FDA require some kind of proof that the drug works before approving it?
Get articles like this delivered to you FREE in our popular email newsletter
|
(FREE) Thursday evening, Dec. 3 at 6pm Pacific (9pm Eastern), call in to hear the NaturalNews Talk Hour with special guests Nick Stern, Sun Warrior Protein & KC Craichy, LivingFuel - "Super Foods, Optimal Health" - Register via email to receive call-in number:
|
|
Explore NaturalPedia.com, the internet's largest natural health encyclopedia of knowledge, covering over 50,000 topics. It's free!
Visit NaturalPedia.com.
|
 FREE Report: The Five Best Anti-Viral Products to Beat Influenza, Swine Flu, Bird Flu and SARS
• Top anti-viral remedies
• Where to get them now
• Four things to avoid
• Become self-reliant
• Boost your family safety
Click here to read the FREE report now.
|
W.H.O. Declares Global Pandemic
Turn FEAR into Confidence!
Listen to the complete 3.5 hour recording on 4 audio CDs of the Health Ranger's Swine Flu Advanced Preparedness Course, covering natural anti-virals, family safety, infrastructure disruptions, quarantine, preparedness gear and much more.
Testimonials:
"Mike Adams' preparedness course turned our fears into confidence. This is POWERFUL information, coming from a trusted source. If you want to save yourself countless hours researching and getting prepared and if you want to do everything in your power to protect your family, I highly recommend the Health Ranger’s Advanced Preparedness Course."
- N. Nelson (Arizona)
"This is packed information no one should miss."
- T. Valenzuela
"Thanks Mike... during this class you covered prevention and preparedness from A to Z with integrity, brave honesty and outstanding knowledge! Thank you for your steadfast, thorough and cool-headed approach to well being. With deep gratitude for your service." - Bev
Available NOW for immediate shipping.
100% satisfaction guarantee
 NEW Product: Valley of Longevity Shampoo from the Health Ranger
• 98% Organic
• 100% Natural
• 100% Fragrance Free!
• No SLS
• No Parabens
• No synthetic chemicals
• FREE shipping in U.S. on orders over $75
Click here to read more...
|
|
|
Wednesday, January 16, 2008
Email this article to a friend
Share this article on: 
